Meditation With Yoga, Group Therapy With Hypnosis, and Psychoeducation For Long-Term Depressed Mood: A Randomized Pilot Trial
Meditation With Yoga, Group Therapy With Hypnosis, and Psychoeducation For Long-Term Depressed Mood: A Randomized Pilot Trial
Meditation With Yoga, Group Therapy With Hypnosis, and Psychoeducation For Long-Term Depressed Mood: A Randomized Pilot Trial
Lisa D. Butler
Stanford University School of Medicine
m
Lynn C. Waelde
Pacific Graduate School of Psychology
m
This study was supported by funds from the Mental Insight Foundation and the Stanford Center on Stress
and Health. The authors thank the people who helped with the conceptualization and implementation of
this study, including Bill Kimpton, Mark Abramson, Jose Maldonado, and Michael Yapko; the volunteer
psychodiagnostic interviewers: Scott Abrams, Chris Ambler, Lagen Biles, Jennifer Devan, Ernest Ellender,
Jocelyn Fine, Zohar Ithzar, Emilian Mihaila, Gina Nguyen, Lisa Paderna, Yana Peleg, Carolyn Sartor,
David Severin, David Spangler, and Bonnie Sullivan; and those who helped with data entry: Shannon
Boustead, Jason Cuff, Jessika Diaz Lara, Carolina Gutierrez, Shelly Henderson, Anna Khaylis, Andrea
Kwan, Daphne Nayar, and Ashwini Palekar. We also thank Jennifer Devan and David J. McIntyre, who
served as meditation interventionists.
Correspondence concerning this article should be addressed to: Dr. Lisa Butler, Department of Psychiatry
and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Room 2320,
Stanford, CA 94305–5718; e-mail: butler@stanford.edu
JOURNAL OF CLINICAL PSYCHOLOGY, Vol. 64(7), 806--820 (2008) & 2008 Wiley Periodicals, Inc.
Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/jclp.20496
Alternative Treatments for Depressed Mood 807
Method
Participants
Demographics. The randomized sample (N 5 46) was 74% female and 26%
male. Mean age of the sample was 50.4 years (SD 5 14.8, range 5 22–80), with an
average of 16.7 years of education (SD 5 3.2, range 5 3–24) and a median total
household income of between $60,000 and $79,000. The primary ethnic background
distribution was 87% Caucasian/White, 9% Asian/Asian American, 2% Hispanic/
Latino, 2% Middle Eastern, 2% American Native/Alaska Native, and 9% other
(Ethnicity percents exceed 100 because several participants endorsed more than one
primary ethnicity.)
Psychiatric characteristics. Based on the information collected in initial clinical
interviews, 50% (n 5 23) of the original sample was diagnosed with dysthymia (a
long-term minor depressive condition), 28% (n 5 13) was diagnosed with ‘‘double
depression’’ (dysthymia with a superimposed MDE), 15.2% (n 5 7) was diagnosed
with an MDE in partial remission, and 6.5% (n 5 3) was diagnosed with chronic
major depression of 2 or more years of duration. Overall, 63% of the sample had
experienced at least one MDE in the past, with half of the sample experiencing three
or more episodes. One individual (2%) was in current individual psychotherapy, 3
(7%) others were in couples therapy, 10 (22%) were taking psychiatric medications
(antidepressant: 7, anxiolytic: 2, both an antidepressant and an anxiolytic: 1), and
none of the participants were taking St. John’s Wort.
If participants met the diagnostic criteria and were not excluded for other reasons,
they were given the Hypnotic Induction Profile (HIP; H. Spiegel & Spiegel, 2004) to
evaluate their level of hypnotizability and were asked to complete a baseline packet
of psychosocial questionnaires assessing life events, general functioning, satisfaction
with life, and aspects of mood (including symptom levels), personality, health, social
support, traumatic experience, and spirituality. These ‘‘paper-and-pencil’’
assessments also were conducted at two additional time points: at approximately 6
months and 9 months following study entry. A second diagnostic interview also was
conducted to determine final clinical status at 9-month follow-up. Research
assistants (RAs) administered the psychosocial questionnaires; trained and
supervised clinical psychology graduate students conducted the diagnostic
interviews, HRSD interviews, and the HIPs. The interviewers and the supervisor
were blind to participant study condition. Of the 46 participants who entered the
study, 3 failed to complete the follow-up assessments (1 hypnosis, 2 control), and an
additional 3 (2 meditation, 1 hypnosis) could not be scheduled for their final follow-
up interview-based assessment.
Inclusion criteria. For inclusion in the study, participants had to (a) meet DSM-
IV (APA, 1994) criteria for a depressive disorder, with the additional requirement
that depressive symptoms had to have lasted for at least the past 2 years without a
remission of 2 months or more. In addition, participants had to be (b) at least 18
years of age, (3) sufficiently proficient in English to be able to participate in group
therapy, and (4) able to attend weekly meetings at Stanford University.
Exclusion criteria. Individuals were excluded from the study if they had (a)
current bipolar disorder or depressive disorder with psychotic features; (b) current or
past psychosis; (c) current primary diagnosis of panic disorder, generalized anxiety
disorder, or posttraumatic stress disorder; (d) current drug or alcohol dependence or
abuse (within the last 3 months); (e) current suicidality beyond simple ideation or
had made prior attempts; (f) a significant medical condition that could interfere with
participation in meditation/yoga; (g) current participation in individual or group
psychotherapy or a meditation group; or (h) started (or changed level or type of)
prescribed antidepressant medication or St. John’s Wort in the previous 3 months.
Of note, although all participants were queried in their initial phone screen about
whether they were currently in psychotherapy (and excluded if they were
participating in individual or group psychotherapy), 1 participant later revealed
(in her baseline treatment history assessment) that she had been receiving such
treatment for 3 years. Due to the small sample size in this study, her data were
retained in the present sample.
Interventions
Therapist-led groups met once a week in the Department of Psychiatry and
Behavioral Sciences at Stanford University School of Medicine to participate in an
intervention that included either meditation and yoga exercises or group therapy
with formal hypnotic inductions.
conducting formal group hypnotic inductions and exercises at the beginning and end
of the meeting aimed at helping participants practice positive affect, increase the
modulation of affect, generate alternative responses, and, where appropriate, explore
life themes and significant life events that participants believed might be related to
their current mood. Participants also were taught self-hypnosis to use outside the
group for relaxation and affect regulation (as described in H. Spiegel & Spiegel,
2004). The group’s experiences using hypnosis were the basis for discussion in the
middle of the group sessions. These were conducted based upon Yalom’s (1985)
‘‘here-and-now’’ group therapy model in which both process and content were
examined in the context of feelings and interactions stimulated in the group during
discussion of depression-related problems. The protocol for this hypnosis
intervention was developed in part from supportive-expressive psychotherapy
(SET; D. Spiegel & Classen, 2000), a group therapy intervention that has been
used to help cancer patients. Additional material was adapted from Yapko’s (1992,
2001) well-delineated program of hypnosis for treating depression.
Measures
Diagnosis. Participants were assessed with the Structured Clinical Interview for
the DSM-IV [SCID-I/P (with Psychotic Screen); First, Spitzer, Gibbon, & Williams,
1998] at baseline and at the 9-month follow-up. The follow-up assessment
determined diagnostic caseness and whether the participant had developed a new
MDE during the course of the study. Interviews were conducted by advanced clinical
psychology graduate students who had been trained in SCID administration and
were supervised by a clinical psychologist (L. W.). Interviewers and the supervisor
were blind to each participant’s study condition.
Depression symptoms. Depression symptoms were assessed with the Hamilton
Rating Scale for Depression (HRSD; Hamilton, 1960). The HRSD is considered by
many to be the ‘‘gold standard’’ of measures of depression severity in large clinical
trials (Demyttenaere & De Fruyt, 2003; Williams, 2001), and its psychometric
properties have been demonstrated to be generally adequate (though they have
recently been called into question; Bagby, Ryder, Schuller, & Marshall, 2004). In the
present study, we used the 26-item version of the measure, and it was administered
by interview at all three assessments. Scores were summed to a total score for
analyses. Cronbach’s a on the HRSD at baseline in this sample was .86.
Dysthymia symptoms. Dysthymia symptoms were assessed with the 27-item
Cornell Dysthymia Rating Scale-Self Report (CDRS-SR; Mason et al., 1995). The
CDRS-SR was developed to assess the frequency and severity of dysthymia
symptoms, some of which may not be adequately assessed with the HRSD. The
clinician-rated version of this measure has been shown to have adequate internal
consistency and construct validity, and greater distributions of severity and better
content validity than the HRSD for dysthymic patients (Hellerstein, Batchelder, Lee,
& Borisovskaya, 2002). Items are rated on a 4-point scale: 1 (none or a little of the
time), 2 (some of the time), 3 (good part of the time), and 4 (most or all of the time).
Cronbach’s a on the CDRS-SR at baseline in this sample was .89.
Treatment history. Treatment history was assessed with a self-report
questionnaire created for this study. Participants were asked at baseline, 6
months, and 9 months whether they were currently in psychotherapy (and if so,
which type, number of sessions, etc.) or taking psychiatric medications or St. John’s
Journal of Clinical Psychology DOI: 10.1002/jclp
Alternative Treatments for Depressed Mood 813
Wort (and if so, which medications, dosage, start date, etc.) as well as questions
about use of alternative therapies (e.g., alternative medications/supplements,
acupuncture, massage, Qi Gong, Reiki, etc.). Use of these alternative therapies
was not examined in the present study.
Data Analyses
Chi-squares were used to examine whether the three groups differed in the
proportion who received outside treatment, and who had remitted or developed an
MDE over the course of the study. Point-biserial correlations and Cramér’s V
coefficients were used to examine the relationship of each outcome to receipt of
outside treatment. Slopes analyses were used to test for differences among groups on
symptom levels (HRSD and CDRS). Each participant with a pre-randomization
baseline measure and at least one post-baseline assessment had a slope constructed
across available assessments regressed on time using months as the unit of time.
Because this was a pilot study, the analyses were not conducted as intention-to-treat.
These outcome slopes became the dependent measure in two analyses of variance
examining treatment effects (meditation vs. hypnosis vs. control) on HRSD
symptom levels and CDRS symptom levels. Because change in symptoms is typically
associated with initial levels, each analysis included the intercept as a covariate. The
intercept was included rather than the baseline value because the intercept is the best
estimate of the true baseline value (Kraemer & Blasey, 2004). All hypothesized
relationships were tested with two-tailed tests (a 5 .05).
Results
Psychotherapy and Antidepressant Use During the Study
The proportion of participants receiving outside treatment at baseline or 9-month
follow-up did not differ significantly among the groups (see Table 1 for baseline and
9-month follow-up use of individual or group psychotherapy and antidepressant
medication).
Table 1
Baseline and 9-Month Follow-Up Number (and %) Receiving Outside Psychotherapy and/or
Antidepressants by Study Condition
Note. Outside psychotherapy includes individual or group psychotherapy. No participant reported use of
St. John’s Wort at baseline or 9-month follow-up.
Table 2
Final Follow-Up Number (and %) of Remissions of Diagnostic Caseness and Presence of
Current Major Depressive Episode (MDE) by Study Condition
Table 3
CDRS and HRSD Means, SDs, and Ranges by Study Condition
CDRS Baseline 15 68.25 12.28 40–89 15 62.47 11.85 45–82 16 67.58 10.02 47–83
CDRS 1st FU 13 58.54 18.10 34–98 12 56.24 10.56 41–79 11 58.27 11.90 42–77
CDRS 2nd FU 13 54.77 12.63 28–74 13 53.15 11.18 37–78 14 58.5 14.24 38–94
CDRS Slopes 15 .053 .031 .11–.00 14 .024 .048 .09–.06 13 .04 .043 .11–.03
HRSD Baseline 15 15.87 7.29 6–29 15 12.33 5.41 5–24 16 15.81 8.01 2–33
HRSD 1st FU 12 14.25 8.99 2–28 12 8.14 5.32 2–17 11 12.90 8.14 0–22
HRSD 2nd FU 13 6.31 5.53 0–19 13 7.31 5.92 2–17 14 12.21 7.67 3–30
HRSD Slopes 15 .022 .027 .06–.04 14 .019 .029 .08–.02 13 .020 .029 .08–.02
Note. CDRS 5 Cornell Dysthymia Rating Scale; HRSD 5 Hamilton Rating Scale for Depression;
FU 5 Follow-up.
over the three assessment points (baseline, 6-month follow-up, and 9-month follow-
up), controlling for initial symptom levels. In this design, the slopes of the CDRS
and HRSD scores were calculated from the data available for each individual who
had completed at least one follow-up. The slopes of the CDRS and HRSD scores
were included as dependent variables in separate ANOVAs, with treatment
condition as the independent variable. In neither case was there a significant effect
of condition on the slope of change across the three assessments. Neither
psychotherapy nor antidepressant use at 9 months was significantly correlated with
the slopes for the CDRS or the HRSD.
Discussion
The present pilot study examined whether meditation with yoga and psychoeduca-
tion or group therapy with hypnosis and psychoeducation could affect diagnostic
status and/or depressive symptoms when compared to psychoeducation alone,
among a sample of adults suffering from long-term depression. We found promising
preliminary support for the use of these interventions to improve diagnostic status
and ward off the development of further MDEs. We did not, though, demonstrate
statistically significant improvement in overall symptom reports over the course of
the study.
Remission rates are usually the primary outcomes for depression studies in
general. Kocsis (2000) noted that the highest remission rates ever reported for
chronic depression are for a combination of antidepressants and psychotherapy
(73% response rate). Our findings that meditation produced a 77% remission rate,
hypnosis produced a 62% remission rate, and the control group experienced a 36%
remission rate indicate that these two nontraditional interventions have potential as
treatments for long-term depressed mood, over and above psychoeducation. Indeed,
even with outside psychotherapy and/or antidepressant medication use (medita-
tion 5 46%, control 5 50%), the meditation group experienced significantly more
remissions than did the control group.
In addition, only participants in our education-only control group developed new
MDEs while participating in the study, which suggests that meditation with yoga
and group therapy with hypnosis may provide some prophylactic effects with respect
to depressive exacerbations of the present condition. However, that these differences
Journal of Clinical Psychology DOI: 10.1002/jclp
816 Journal of Clinical Psychology, July 2008
in rates of new episodes did not reach statistical significance. Clearly, these findings
warrant additional exploration and future replication.
With respect to the clinical significance of our findings, it is noteworthy that
although the two diagnostic status variables appeared to be affected by the
interventions, we did not find an overall difference in symptom-level decline between
groups. This highlights the importance of assessing changes in overall diagnostic
profile in addition to simple symptom levels to yield clinically meaningful
information. Moreover, examination of the symptom-level means over the course
of the assessments suggests that change appears to have taken time in this sample,
and it could be that an extended period of practice is needed to see the benefits of
these interventions for a chronic depressive condition. Although some meditation
studies have found pre–post improvements in symptoms after only 8 weeks (e.g.,
Waelde et al., 2004), to yield improvement in chronic depression, future
implementations may require a longer intervention period.
Depression can be understood as a disorder in which mood dominates cognition,
rendering it relatively inflexible and reducing opportunities to alter it. While clearly
cognitive (Beck, Rush, Shaw, & Emery, 1979) and interpersonal (Weissman, 2007a,
2007b) psychotherapies can be helpful, it makes sense that other techniques designed
to alter mental states, such as mindfulness (Bruckstein, 1999; Kabat-Zinn, 1994;
Kabat-Zinn, Massion, Herbert, & Rosenbaum, 1998; Rosch, 1997) and hypnosis (H.
Spiegel & Spiegel, 2004), also might affect depression (Yapko, 2001). These
techniques may work by teaching depressed individuals means of altering their
current mental state, providing flexibility in altering the typically unremitting pall of
sadness experienced in depression. Meditation in the Classical Yoga tradition may be
used to let go of thoughts that maintain the depressive affect. Hypnosis can be and
was utilized to combine a pleasant sense of physical relaxation with a restructuring of
situations that typically exacerbate depression (e.g., picturing an apparently
humiliating encounter with a boss from the perspective of a third party who might
have reached a very different conclusion about what had happened). Thus, both
approaches may combine learning skills designed to alter the mental and physical
state with amplification of principles utilized in cognitive and interpersonal
psychotherapy of depression.
A number of important limitations to the present study should be considered when
drawing conclusions from these data. One limitation was that there were marked
challenges in recruiting our sample and in retaining them over the course of the
study. Some participants became discouraged with their group assignment, and
others refused to participate in follow-up assessments. Some of these difficulties may
be attributable to characteristics of the population under study, whose symptoms
may include lower motivation and poor treatment compliance (Hübner-Liebermann,
Spiessl, & Cording, 2001). Moreover, there may have been additional factors that
influenced the makeup of our final sample, and possibly limited its representative-
ness, such as whether the sample was restricted to those who found alternative (i.e.,
nontraditional) forms of treatment appealing, the level of severity of participants’
conditions associated with a desire for alternative treatment, and participants’
willingness to participate in a randomized treatment protocol lasting several months.
Additionally, the sample was mixed with respect to mood disorder diagnosis, which
added variability to the sample. While all participants had experienced a clinically
significant, long-term, relatively low-grade depressive disorder, they varied in a
number of ways, including their history of MDEs, age at initial onset, and length of
current condition. The small sample size did not offer enough power to examine
Journal of Clinical Psychology DOI: 10.1002/jclp
Alternative Treatments for Depressed Mood 817
References
Abrams, S. (1964). Implications of learning theory in treatment of depression by employing
hypnosis as an adjunctive technique. American Journal of Clinical Hypnosis, 13, 313–321.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental
disorders (4th ed.). Washington, DC: Author.
Bagby, R.M., Ryder, A.G., Schuller, D.R., & Marshall, M.B. (2004). The Hamilton
Depression Rating Scale: Has the gold standard become a lead weight? American Journal
of Psychiatry, 161(12), 2163–2177.
Beach, S.R., & O’Leary, K.D. (1992). Treating depression in the context of marital discord:
Outcome and predictors of response of marital therapy versus cognitive therapy.
Behavioral Therapy, 23(4), 507–528.
Beck, A., Rush, A., Shaw, B., & Emery, G. (1979). Cognitive therapy of depression. New
York: Guilford Press.
Journal of Clinical Psychology DOI: 10.1002/jclp
818 Journal of Clinical Psychology, July 2008
Kabat-Zinn, J. (1994). Full catastrophe living: Using the wisdom of your body and mind to
face stress, pain and illness. New York: Delacorte Press.
Kabat-Zinn, J., Massion, A.O., Herbert, J.R., & Rosenbaum, E. (1998). Meditation. In J.
Holland (Ed.), Psychooncology (pp. 767–779). New York: Oxford University Press.
Kabat-Zinn, J., Massion, A.O., Kristeller, J., Peterson, L.G., Fletcher, K.E., Pbert, L., et al.
(1992). Effectiveness of a meditation-based stress reduction program in the treatment of
anxiety disorders. American Journal of Psychiatry, 149(7), 936–943.
Keller, M.B., Gelenberg, A.J., Hirschfeld, R.M., Rush, A.J., Thase, M.E., Kocsis, J.H., et al.
(1998). The treatment of chronic depression, Part 2: A double-blind, randomized trial of
sertraline and imipramine. Journal of Clinical Psychiatry, 59(11), 598–607.
Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., et al.
(1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the
United States. Results from the National Comorbidity Survey. Archives of General
Psychiatry, 51(1), 8–19.
Klein, D.N., Dickstein, S., Taylor, E.B., & Harding, K. (1989). Identifying chronic affective
disorders in outpatients: Validation of the General Behavior Inventory. Journal of
Consulting and Clinical Psychology, 57(1), 106–111.
Kocsis, J.H. (2000). New strategies for treating chronic depression. Journal of Clinical
Psychiatry, 61(Suppl. 11), 42–45.
Kocsis, J.H., Zisook, S., Davidson, J., Shelton, R., Yonkers, K., Hellerstein, D.J., et al. (1997).
Double-blind comparison of sertraline, imipramine, and placebo in the treatment of
dysthymia: Psychosocial outcomes. American Journal of Psychiatry, 154(3), 390–395.
Kraemer, H.C., & Blasey, C.M. (2004). Centring in regression analyses: A strategy to prevent
errors in statistical inference. International Journal of Methods in Psychiatric Research,
13(3), 141–151.
Markowitz, J.C. (1994). Psychotherapy of dysthymia. American Journal of Psychiatry, 151(8),
1114–1121.
Markowitz, J.C., Moran, M.E., Kocsis, J.H., & Frances, A.J. (1992). Prevalence and
comorbidity of dysthymic disorder among psychiatric outpatients. Journal of Affective
Disorders, 24(2), 63–71.
Mason, B.J., Kocsis, J.H., Leon, A.C., Thompson, S., Frances, A.J., Morgan, R.O., et al.
(1995). Assessment of symptoms and change in dysthymic disorder. In J.H. Kocsis & D.N.
Klein (Eds.), Diagnosis and treatment of chronic depression (pp. 73–88). New York:
Guilford Press.
McCullough, J.P., Klein, D.N., Borian, F.E., Howland, R.H., Riso, L.P., Keller, M.B., et al.
(2003). Group comparisons of DSM-IV subtypes of chronic depression: Validity of the
distinctions, Part 2: Journal of Abnormal Psychology, 112(4), 614–622.
Miller, J.J., Fletcher, K., & Kabat-Zinn, J. (1995). Three-year follow-up and clinical
implications of a mindfulness meditation-based stress reduction intervention in the
treatment of anxiety disorders. General Hospital Psychiatry, 17(3), 192–200.
Mossey, J.M., Knott, K.A., Higgins, M., & Talerico, K. (1996). Effectiveness of a
psychosocial intervention, interpersonal counseling, for subdysthymic depression in
medically ill elderly. Journals of Gerontology Series A: Biological Sciences and Medical
Sciences, 51(4), M172–M178.
Nolen-Hoeksema, S. (2000). The role of rumination in depressive disorders and mixed anxiety/
depressive symptoms. Journal of Abnormal Psychology, 109(3), 504–511.
Pilkington, K., Kirkwood, G., Rampes, H., & Richardson, J. (2005). Yoga for depression: The
research evidence. Journal of Affective Disorders, 89(1–3), 13–24.
Rosch, E. (1997). Mindfulness meditation and the private (?) self. In U. Neisser & D.A.
Jopling (Eds.), The conceptual self in context: Culture, experience, self-understanding
(pp. 185–202). The Emory Symposia in Cognition. New York: Cambridge University Press.
Journal of Clinical Psychology DOI: 10.1002/jclp
820 Journal of Clinical Psychology, July 2008
Shapiro, S.L., Schwartz, G.E., & Bonner, G. (1998). Effects of mindfulness-based stress
reduction on medical and premedical students. Journal of Behavioral Medicine, 21(6),
581–599.
Shelton, R.C., Davidson, J., Yonkers, K.A., Koran, L., Thase, M.E., Pearlstein, R., et al.
(1997). The undertreatment of dysthymia. Journal of Clinical Psychiatry, 58(3), 59–65.
Spiegel, D. (1990). Facilitating emotional coping during treatment. Cancer, 16(S14),
1422–1426.
Spiegel, D. (1994). Hypnosis. In R.E. Hales, S.C. Yudofsky, & J.A. Talbott (Eds.), The
American Psychiatric Press textbook of psychiatry (2nd ed., pp. 1115–1142). Washington,
DC: American Psychiatric Association.
Spiegel, D., & Classen, C. (2000). Group therapy for cancer patients: A research-based
handbook of psychosocial care. New York: Basic Books.
Spiegel, H., & Spiegel, D. (2004). Trance and treatment: Clinical uses of hypnosis. Arlington,
VA: American Psychiatric Publishing Inc.
Teasdale, J.D., Moore, R.G., Hayhurst, H., Pope, M., Williams, S., & Segal, Z.V. (2002).
Metacognitive awareness and prevention of relapse in depression: Empirical evidence.
Journal of Consulting and Clinical Psychology, 70(2), 275–287.
Teasdale, J.D., Segal, Z.V., Williams, J.M., Ridgeway, V.A., Soulsby, J.M., & Lau, M.A.
(2000). Prevention of relapse/recurrence in major depression by mindfulness-based
cognitive therapy. Journal of Consulting and Clinical Psychology, 68(4), 615–623.
Tloczynski, J., & Tantriella, M. (1998). A comparison of the effects of Zen breath meditation
or relaxation on college adjustment. Psychologia, 41(1), 32–43.
Waelde, L.C. (1999). Inner resources: A psychotherapeutic program of yoga and meditation.
Unpublished treatment manual and materials. (Available from the Inner Resources Center,
Pacific Graduate School of Psychology, 405 Broadway Street, Redwood City, CA 94063.)
Waelde, L.C. (2004). Dissociation and meditation. Journal of Trauma and Dissociation, 5,
147–162.
Waelde, L.C., Thompson, L., & Gallagher-Thompson, D. (2004). A pilot study of a yoga and
meditation intervention for dementia caregiver stress. Journal of Clinical Psychology,
60(6), 677–687.
Weissman, M.M. (2007a). Cognitive therapy and interpersonal psychotherapy: 30 years later.
American Journal of Psychiatry, 164(5), 693–696.
Weissman, M.M. (2007b). Recent non-medication trials of interpersonal psychotherapy for
depression. Journal of Neuropsychopharmacology, 10(1), 117–122.
Weissman, M.M., Leaf, P.J., Bruce, M.L., & Florio, L. (1998). The epidemiology of
dysthymia in five communities: Rates, risks, comorbidity, and treatment. American Journal
of Psychiatry, 145(7), 815–819.
Wells, D.A., & Lennon, S.R. (1989). Major depression and amyloidosis. General Hospital
Psychiatry, 11(6), 425–426.
Williams, J.B. (2001). Standardizing the Hamilton Depression Rating Scale: Past, present, and
future. European Archives of Psychiatry and Clinical Neuroscience, 251(Suppl. 2),
II6–II12.
Yalom, I.D. (1985). The theory and practice of group psychotherapy. New York: Basic Books.
Yapko, M.D. (1990). Trancework: An introduction to the practice of clinical hypnosis.
Philadelphia, PA: Brunner/Mazel.
Yapko, M.D. (1992). Hypnosis and the treatment of depressions: Strategies for change.
Philadelphia, PA: Brunner/Mazel.
Yapko, M.D. (2001). Treating depression with hypnosis. Philadelphia: Brunner-Routledge.